Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT05311904
Eligibility Criteria:
Inclusion Criteria:
1. Patient with one of the following neuromuscular diseases:
* Autoimmune myasthenia gravis, Lambert-Eaton syndrome
* Congenital myasthenic syndromes
* Myositis
* Inflammatory neuropathies
* Hereditary neuropathies (Charcot-Marie-Tooth disease, etc.)
* Amyloid neuropathies
* Spinal atrophies
* Myotonic dystrophies type 1 (Steinert disease) and 2 (PROMM)
* Duchenne and Becker muscular dystrophies
* Muscular dystrophies of the girdles
* Pump disease
* Congenital myopathies
* Congenital muscular dystrophies
* Metabolic myopathies
* Other myopathies with confirmed genetic diagnosis
2. Patient over 18 years old
3. Patient having understood that the follow-up of a possible side effect of the vaccination or of a COVID-19 must be carried out by his usual doctor (s) and not by the observatory team Va-C-NEMUS
4. Patients having been informed of the study and having expressed their agreement
Exclusion Criteria:
1\. Patient under legal protection, curatorship or tutorship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05311904
Study Brief:
Protocol Section:
NCT05311904